Head Lice Clinical Trial
Official title:
An Open Label Randomized Study to Compare the Safety and Efficacy of Silcap Plus (Approximately 4% Dimeticone) Against Nix Cream Rinse.
Verified date | May 2008 |
Source | Oystershell NV |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study was to evaluate the efficacy of a dimethicone foam in the control of head lice and to compare the efficacy to a permethrin based product.
Status | Completed |
Enrollment | 31 |
Est. completion date | November 2007 |
Est. primary completion date | November 2007 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 4 Years to 85 Years |
Eligibility |
Inclusion Criteria: - 4 - 85 years of age - active head lice infestation of at least = 10 live lice - short hair (hair no longer than 2 inches below the neck) or long hair (hair 2 inches below the neck to mid back) Exclusion Criteria: - had received or used an investigational new drug within the 30 days immediately preceding the study - used any form of head lice treatment whether prescription, over-the-counter, or a home remedy for at least fourteen days prior to their study visit - used topical medication of any kind on the hair for a period of 48 hours prior to the visit - had a history of allergy to rag weed, permethrin, or mineral oil, or had taken trimethoprim or cotrimoxazole at evaluation or during the previous four weeks - Female subjects that were pregnant or breast feeding |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Lice Source Services Inc | Plantation | Florida |
Lead Sponsor | Collaborator |
---|---|
Oystershell NV |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cure rate at the final visit (Day 14 or 15). Cure rate was defined as the number of subjects free of live head lice divided by the total number of subjects in the treatment group (x 100). | 14 or 15 days after 1st treatment | No | |
Secondary | Any adverse events during or after application of the product | up to 7 or 8 d after product application | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00988533 -
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
|
Phase 1 | |
Completed |
NCT00858481 -
A Pilot Dose Ranging Study of Spinosad Creme Rinse
|
Phase 2 | |
Completed |
NCT03301649 -
Clinical Endpoint Study of Ivermectin 0.5% Lotion
|
Phase 3 | |
Completed |
NCT00994422 -
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 2 | |
Completed |
NCT00995124 -
Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application
|
Phase 4 | |
Completed |
NCT03337490 -
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
|
Phase 3 | |
Completed |
NCT06333054 -
Safety and Efficacy of a Head Lice Shampoo
|
N/A | |
Completed |
NCT02213055 -
Pediatric Head Lice Study Product Comparison
|
Phase 2 | |
Completed |
NCT02974088 -
Neem Lotion With Combing for Lice
|
Phase 2 | |
Recruiting |
NCT05379114 -
Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation
|
N/A | |
Completed |
NCT03617926 -
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
|
N/A | |
Completed |
NCT01803581 -
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
|
N/A | |
Completed |
NCT01066585 -
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
|
Phase 3 | |
Completed |
NCT01068158 -
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 3 | |
Completed |
NCT00857935 -
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
|
Phase 2 | |
Completed |
NCT00301340 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
|
Phase 3 | |
Completed |
NCT02062073 -
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
|
Phase 1 | |
Completed |
NCT02061813 -
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
|
Phase 1 | |
Completed |
NCT00605956 -
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00301327 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.
|
Phase 3 |